Aptose Bioscns (APTO)

$1.18 0.05 (4.06%)

15:43 EDT APTO Stock Quote Delayed 30 Minutes

APTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024

By InvestorPlace Earnings May 14, 2024

APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the first quarter of 2024.

APTO Stock Earnings: Aptose Biosciences Beats EPS for Q4 2023

Why Is Aptose Biosciences (APTO) Stock Down Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

More Articles

Volume:

Previous Close -

Market Cap 110.52M

PE Ratio -4.54

EPS -0.26

Volume (Avg. Vol.) 42,831

Day's Range $1.18 - $1.25

52-Week Range $0.36 - $6.60

Dividend & Yield N/A (N/A)

APTO Stock Predictions, Articles, and Aptose Bioscns News

From InvestorPlace
From the Web

3 Stocks With 1,000% Upside Potential

By Omor Ibne Ehsan May 21, 2023

If you're an investor comfortable with speculative bets, analysts are price targeting these stocks with 1000% upside.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Feb 13, 2023

It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 23, 2022

Rise and shine, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Mar 3, 2022

Good morning! In preparation for another busy day of trading, we've put together a list of the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 14, 2021

Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Apr 29, 2021

Good morning! We're getting ready for another day of trading with a list of the top pre-market stock movers for Thursday.

APTO Stock: Why Aptose Biosciences Is Rocketing Higher Today

By Brenden Rearick, InvestorPlace Financial News Writer Mar 24, 2021

APTO stock is rocketing this morning as the company releases some encouraging research details alongside its Q4 earnings report.

Aptose Biosciences files to sell ordinary shares, warrants (NASDAQ:APTO)

From Seeking Alpha Dec 4, 2023

Aptose Biosciences (APTO) Friday filed a prospectus related to the proposed sale of its 4.09M ordinary shares and pre-funded warrants. This prospectus is not an

Aptose Biosciences meets Nasdaq compliance requirement (NASDAQ:APTO)

From Seeking Alpha Jun 27, 2023

Clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, Aptose Biosciences (APTO) receives Nasdaq notice that...

Aptose Biosciences updates on reverse stock split (NASDAQ:APTO)

From Seeking Alpha Jun 5, 2023

Aptose Biosciences (APTO) has effected a reverse stock split on at a ratio of 15-to-1, effective at market open on Tuesday, June 6, 2023.The company had previously announced that...

Aptose to sell up to $25M stock in the U.S. (NASDAQ:APTO)

From Seeking Alpha May 25, 2023

Aptose Biosciences (APTO) (APS:CA) said Thursday it has entered into a $25 million common share purchase agreement and registration rights agreement with an institutional investor

JonesTrading Keeps Their Buy Rating on Aptose Biosciences (APTO)

From TipRanks Dec 12, 2022

JonesTrading analyst Soumit Roy maintained a Buy rating on Aptose Biosciences (APTO – Research Report) today and set a price target of $5.00. The c...

Aptose Biosciences (APTO) Gets a Buy from H.C. Wainwright

From TipRanks Nov 17, 2022

In a report released on November 14, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Aptose Biosciences (APTO – Research Report), with a pric...

ADVERTISEMENT